Literature DB >> 3098919

Biotin transport through the blood-brain barrier.

R Spector, D Mock.   

Abstract

The unidirectional influx of biotin across cerebral capillaries, the anatomical locus of the blood-brain barrier, was measured with an in situ rat brain perfusion technique employing [3H]biotin. Biotin was transported across the blood-brain barrier by a saturable system with a one-half saturation concentration of approximately 100 microM. The permeability-surface area products were 10(-4) s-1 with a biotin concentration of 0.02 microM in the perfusate. Probenecid, pantothenic acid, and nonanoic acid but not biocytin or biotin methylester (all 250 microM) inhibited biotin transfer through the blood-brain barrier. The isolated rabbit choroid plexus was unable to concentrate [3H]biotin from medium containing 1 nM [3H]biotin. These observations provide evidence that: biotin is transported through the blood-brain barrier by a saturable transport system that depends on a free carboxylic acid group, and the choroid plexus is probably not involved in the transfer of biotin between blood and cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3098919     DOI: 10.1111/j.1471-4159.1987.tb04107.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

Review 1.  The sodium/multivitamin transporter: a multipotent system with therapeutic implications.

Authors:  Matthias Quick; Lei Shi
Journal:  Vitam Horm       Date:  2015-03-07       Impact factor: 3.421

Review 2.  Proximity labeling: spatially resolved proteomic mapping for neurobiology.

Authors:  Shuo Han; Jiefu Li; Alice Y Ting
Journal:  Curr Opin Neurobiol       Date:  2017-11-08       Impact factor: 6.627

3.  Targeting the sodium-dependent multivitamin transporter (SMVT) for improving the oral absorption properties of a retro-inverso Tat nonapeptide.

Authors:  S Ramanathan; S Pooyan; S Stein; P D Prasad; J Wang; M J Leibowitz; V Ganapathy; P J Sinko
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

4.  Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3.

Authors:  Wen-Qi Zeng; Eiman Al-Yamani; James S Acierno; Susan Slaugenhaupt; Tammy Gillis; Marcy E MacDonald; Pinar T Ozand; James F Gusella
Journal:  Am J Hum Genet       Date:  2005-05-03       Impact factor: 11.025

5.  Selective accumulation of biotin in arterial chemoreceptors: requirement for carotid body exocytotic dopamine secretion.

Authors:  Patricia Ortega-Sáenz; David Macías; Konstantin L Levitsky; José A Rodríguez-Gómez; Patricia González-Rodríguez; Victoria Bonilla-Henao; Ignacio Arias-Mayenco; José López-Barneo
Journal:  J Physiol       Date:  2016-10-09       Impact factor: 5.182

6.  Biotin-responsive basal ganglia disease: neuroimaging features before and after treatment.

Authors:  H Kassem; A Wafaie; S Alsuhibani; T Farid
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-08       Impact factor: 3.825

7.  Leigh-Like Syndrome Due to Homoplasmic m.8993T>G Variant with Hypocitrullinemia and Unusual Biochemical Features Suggestive of Multiple Carboxylase Deficiency (MCD).

Authors:  Shanti Balasubramaniam; B Lewis; D M Mock; H M Said; M Tarailo-Graovac; A Mattman; C D van Karnebeek; D R Thorburn; R J Rodenburg; J Christodoulou
Journal:  JIMD Rep       Date:  2016-07-22

8.  Biotin uptake and transport across bovine brain microvessel endothelial cell monolayers.

Authors:  F Shi; C Bailey; A W Malick; K L Audus
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

9.  Na(+)-dependent biotin transport into brush-border membrane vesicles from human kidney cortex.

Authors:  B Baur; E R Baumgartner
Journal:  Pflugers Arch       Date:  1993-02       Impact factor: 3.657

10.  Management of a patient with holocarboxylase synthetase deficiency.

Authors:  Johan L K Van Hove; Sagi Josefsberg; Cynthia Freehauf; Janet A Thomas; Le Phuc Thuy; Bruce A Barshop; Michael Woontner; Donald M Mock; Pei-Wen Chiang; Elaine Spector; Iván Meneses-Morales; Rafael Cervantes-Roldán; Alfonso León-Del-Río
Journal:  Mol Genet Metab       Date:  2008-10-29       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.